Update on human African trypanosomiasis (sleeping sickness).


Journal

Journal of neurology
ISSN: 1432-1459
Titre abrégé: J Neurol
Pays: Germany
ID NLM: 0423161

Informations de publication

Date de publication:
Sep 2019
Historique:
received: 28 05 2019
accepted: 06 06 2019
pubmed: 19 6 2019
medline: 29 1 2020
entrez: 19 6 2019
Statut: ppublish

Résumé

Human African trypanosomiasis (HAT), also known as sleeping sickness, is one of the Africa's 'neglected diseases' and is caused by infection with protozoan parasites of the Trypanosoma genus. Transmitted by the bite of the tsetse fly, it puts 70 million people at risk throughout sub-Saharan Africa and is usually fatal if untreated or inadequately treated. In this brief overview, some important recent developments in this disease are outlined. These cover various aspects including a reduction in disease incidence, newly recognised parasite reservoir sites in humans, disease outcome, novel diagnostic methods, new and improved treatment, and disease neuropathogenesis.

Identifiants

pubmed: 31209574
doi: 10.1007/s00415-019-09425-7
pii: 10.1007/s00415-019-09425-7
doi:

Substances chimiques

Benzamides 0
Boron Compounds 0
SCYX 7158 0

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

2334-2337

Références

J Clin Invest. 2004 Feb;113(4):496-504
pubmed: 14966556
Ann Trop Med Parasitol. 2004 Jun;98(4):329-37
pubmed: 15228714
Int J Parasitol. 2006 May 1;36(5):505-12
pubmed: 16546191
Ann Neurol. 2008 Aug;64(2):116-26
pubmed: 18756506
Lancet. 2009 Jul 4;374(9683):56-64
pubmed: 19559476
PLoS Negl Trop Dis. 2010 Dec 07;4(12):e906
pubmed: 21151878
Am J Trop Med Hyg. 2011 Feb;84(2):344-50
pubmed: 21292912
PLoS Negl Trop Dis. 2011 Jun;5(6):e1151
pubmed: 21738803
PLoS Negl Trop Dis. 2011 Sep;5(9):e1308
pubmed: 21909447
J Travel Med. 2012 Jan-Feb;19(1):44-53
pubmed: 22221811
PLoS Negl Trop Dis. 2012;6(6):e1691
pubmed: 22720107
PLoS One. 2012;7(8):e43913
pubmed: 22952808
PLoS Negl Trop Dis. 2012;6(10):e1859
pubmed: 23145192
Lancet Neurol. 2013 Feb;12(2):186-94
pubmed: 23260189
PLoS Negl Trop Dis. 2013 Aug 22;7(8):e2384
pubmed: 23991236
PLoS Negl Trop Dis. 2014 Dec 18;8(12):e3349
pubmed: 25522322
PLoS Negl Trop Dis. 2016 Apr 08;10(4):e0004608
pubmed: 27058033
Elife. 2016 Sep 22;5:
pubmed: 27653219
Methods. 2017 Aug 15;127:79-87
pubmed: 28636879
Lancet. 2017 Nov 25;390(10110):2397-2409
pubmed: 28673422
Trans R Soc Trop Med Hyg. 2017 May 1;111(5):199-203
pubmed: 28957467
Lancet. 2018 Jan 13;391(10116):144-154
pubmed: 29113731
PLoS Negl Trop Dis. 2018 Mar 28;12(3):e0006386
pubmed: 29590116
Front Immunol. 2019 Jan 25;10:39
pubmed: 30740102

Auteurs

Peter G E Kennedy (PGE)

Institute of Infection, Immunity and Inflammation, College of Medical, Veterinary and Life Sciences, University of Glasgow, Garscube Campus, Glasgow, G61 1QH, Scotland, UK. Peter.Kennedy@glasgow.ac.uk.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH